EROSIVE PREPYLORIC CHANGES IN PATIENTS WITH END-STAGE RENAL-FAILURE UNDERGOING MAINTENANCE DIALYSIS TREATMENT

被引:8
|
作者
KANG, JY
WEE, A
CHOONG, HL
WU, AYT
机构
[1] NATL UNIV SINGAPORE HOSP,DEPT PATHOL,SINGAPORE,SINGAPORE
[2] SINGAPORE GEN HOSP,DEPT RENAL MED,SINGAPORE,SINGAPORE
关键词
Campylobacter; Gastritis; Gastroscopy; Haemodialysis; Uraemia;
D O I
10.3109/00365529008997602
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
We endoscoped 322 of 422 patients with end-stage renal failure undergoing maintenance dialysis treatment to determine the prevalence of erosive prepyloric changes (EPC) in uraemia. EPC grade 1 was found in 79 patients (25% grade 2 in 16 (5% and grade 3 in 43 (13% EPC grades 2 and 3 were commoner among uraemic patients than among non-uraemic patients presenting for gastroduodenoscopy (13 of 198 = 6%; p < 0.001). Patients with EPC grades 2 and 3 were older, had been receiving dialysis longer, and were more likely to be receiving haemodialysis rather than peritoneal dialysis when compared with patients without EPC. Histologic gastritis of the body and antrum was less common among patients with EPC grades 2 and 3 than among patients without EPC. The prevalence of Campylobacter-like organisms was similar in patients with and without EPC. © 1990 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted.
引用
收藏
页码:746 / 750
页数:5
相关论文
共 50 条
  • [21] ACTIVE TREATMENT OF CHILDREN WITH END-STAGE RENAL-FAILURE
    KING, SY
    BUTTIMORE, A
    LYNN, KL
    BAILEY, RR
    [J]. NEW ZEALAND MEDICAL JOURNAL, 1982, 95 (719) : 763 - 766
  • [22] SECONDARY MANIFESTATIONS IN END-STAGE RENAL-FAILURE AND THEIR TREATMENT
    ROCKEL, A
    ABDELHAMID, S
    MENTH, M
    [J]. MEDIZINISCHE WELT, 1992, 43 (01): : 55 - 60
  • [23] ECONOMY AND MANAGEMENT OF THE END-STAGE RENAL-FAILURE TREATMENT
    CONDE, JL
    [J]. NEFROLOGIA, 1994, 14 : 3 - 9
  • [24] RENAL OSTEODYSTROPHY IN END-STAGE RENAL-FAILURE PATIENTS IN ISRAEL
    BONER, G
    OLAH, AJ
    WEISS, A
    SEELENFREUND, MZ
    ROSENFELD, JB
    [J]. ISRAEL JOURNAL OF MEDICAL SCIENCES, 1983, 19 (07): : 608 - 613
  • [25] COMPARISON OF THE EFFECTS OF MUZOLIMINE AND FUROSEMIDE IN PATIENTS WITH END-STAGE RENAL-FAILURE ON CHRONIC DIALYSIS
    SCHMIDT, P
    LOEW, D
    DYCKA, J
    KOPSA, H
    BALCKE, P
    ZAZGORNIK, J
    DEUTSCH, E
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 20 (01) : 23 - 26
  • [26] PHARMACOLOGY OF VECURONIUM IN PATIENTS WITH END-STAGE RENAL-FAILURE
    MEISTELMAN, C
    LIENHART, A
    LEVEQUE, C
    BITKER, MO
    PIGOT, B
    VIARS, P
    [J]. EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 1986, 3 (02) : 153 - 158
  • [27] PHARMACOKINETICS OF KETOPROFEN IN PATIENTS WITH END-STAGE RENAL-FAILURE
    GRUBB, NG
    RUDY, DW
    HALL, SD
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 57 (02) : 222 - 222
  • [28] IMMUNOGLOBULIN ALLOTYPES IN PATIENTS IN END-STAGE RENAL-FAILURE
    LAUNDY, GJ
    BRADLEY, BA
    [J]. JOURNAL OF IMMUNOGENETICS, 1985, 12 (4-5): : 181 - 190
  • [29] INTERMITTENT PERITONEAL-DIALYSIS IN THE MANAGEMENT OF END-STAGE RENAL-FAILURE
    WALKER, RG
    ATKINS, RC
    THOMSON, NM
    SCOTT, DF
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1980, 10 (01): : 119 - 119
  • [30] Hospitalizations in dialysis end-stage renal failure patients
    Morduchowicz, G
    Boner, G
    [J]. NEPHRON, 1996, 73 (03): : 413 - 416